Andrea S. Blevins Primeau, PhD, MBA

New research suggests that US cancer survivors are more likely than the general population to develop moderate to severe COVID-19 and long COVID.

Patients with low-risk cervical cancer have similar rates of pelvic recurrence whether they undergo simple or radical hysterectomy, a new study suggests.

Traveling oncologists can reduce travel times for rural cancer patients receiving chemotherapy and radiotherapy, a new study suggests.

Researchers found that historical redlining and contemporary mortgage discrimination were associated with breast cancer outcomes, but associations varied by race.

Adding perioperative tislelizumab to neoadjuvant chemotherapy and surgery can improve outcomes in patients with NSCLC, a phase 3 trial suggests.

Researchers sought to determine whether treatment of relapsed/refractory CLL or SLL with venetoclax plus obinutuzumab would lead to durable responses.

New research suggests that hypofractionated radiotherapy and conventional fractionated radiotherapy largely produce similar outcomes in patients who have undergone breast cancer surgery.

Adding pegargiminase to standard chemotherapy can improve outcomes in patients with chemotherapy-naïve, nonepithelioid pleural mesothelioma, data suggest.

Patients receiving alpelisib for advanced breast cancer may be at risk of developing diabetic ketoacidosis, data suggest.

Medical oncologists are less likely than other oncology specialists to consider metastasis-directed therapy for colorectal cancer, a survey suggests.